Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Regular ✕Edelweiss Recently Listed IPO Fund · Regular ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseITIEdelweiss
NAV₹18.7412₹33.4822
NAV date20 Nov 202620 Nov 2026
History5.0 years8.7 years
Expense ratio2.6%2.7%
Stars★★★★★★★★★★
Growth Score68.8044.70

Returns

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
1 month+11.19%+5.80%
3 months+3.97%+2.08%
6 months+11.37%+19.60%
YTD+19.43%+23.82%
1 year+15.93%+22.21%
3 years (CAGR)+17.74%+15.66%
5 years (CAGR)+13.47%+9.59%
10 years (CAGR)——
Since launch+13.30%+14.82%

Risk

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Volatility15.9%20.9%
Downside volatility10.3%13.1%
Sharpe0.710.44
Sortino1.090.70
Calmar1.010.63
Return / risk1.120.75
Deepest fall−18.53%−32.34%
Days to recover384155
Below its high+0.00%−1.65%

Against benchmark

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Alpha−3.15%+4.43%
Beta0.980.97
R²84.6%56.3%
Up capture90.7%111.0%
Down capture104.0%96.2%
Tracking error6.2%13.8%
Information ratio−0.560.31
Treynor0.100.09

Consistency

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Best 1-year+58.89%+97.69%
Middle 1-year+13.39%+16.18%
Worst 1-year−11.02%−24.34%
1-year periods with a loss25.6%26.2%
Middle 3-year+19.00%+17.58%
Positive months69.4%66.7%
Best day+3.48%+3.68%
Worst day−3.29%−5.79%
Worst 5% day−1.48%−1.94%
Positive days55.6%57.4%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
5-year XIRR—+16.40%
5-year value—₹9,11,471
3-year XIRR+13.53%+16.90%
1-year XIRR+25.62%+33.64%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth